Adrenal Gland Diseases
Welcome,         Profile    Billing    Logout  
 33 Companies   41 Products   41 Products   43 Mechanisms of Action   3 Trials   257 News 


123456»
  • ||||||||||  Opdivo (nivolumab) / Ono Pharma, BMS
    Trial completion date, Trial termination, PD(L)-1 Biomarker, Metastases:  Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer (clinicaltrials.gov) -  May 1, 2019   
    P2,  N=10, Terminated, 
    Completed --> Terminated; recruitment difficulties Trial completion date: May 2020 --> Nov 2018 | Active, not recruiting --> Terminated; Study did not meet first stage requirements of interim analysis
  • ||||||||||  Trial completion, Trial completion date:  11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism (clinicaltrials.gov) -  Mar 11, 2019   
    P=N/A,  N=40, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2022 --> Mar 2019
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  Cortisol Response to Low Dose Cosyntropin Stimulation Test in the Late Afternoon (clinicaltrials.gov) -  Jan 18, 2019   
    P=N/A,  N=20, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Aug 2018 | Trial primary completion date: Aug 2017 --> Aug 2018
  • ||||||||||  Clinical data, Trial completion, Surgery:  Impact of Pre-operative Steroids on Adrenal Insufficiency (clinicaltrials.gov) -  Jan 16, 2019   
    P=N/A,  N=50, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Aug 2018 | Trial primary completion date: Aug 2017 --> Aug 2018 Active, not recruiting --> Completed
  • ||||||||||  everolimus / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date:  Open-label Study on Treatment of Primary Aldosteronism With Everolimus (clinicaltrials.gov) -  Jan 9, 2019   
    P2,  N=12, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018 | Trial primary completion date: Dec 2018 --> Jun 2018
  • ||||||||||  Clinical data, Enrollment closed, Surgery:  Impact of Pre-operative Steroids on Adrenal Insufficiency (clinicaltrials.gov) -  Dec 24, 2018   
    P=N/A,  N=50, Active, not recruiting, 
    Recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018 | Trial primary completion date: Dec 2018 --> Jun 2018 Recruiting --> Active, not recruiting
  • ||||||||||  Clinical data, Trial completion date, Trial primary completion date, Surgery:  Impact of Pre-operative Steroids on Adrenal Insufficiency (clinicaltrials.gov) -  Jul 18, 2018   
    P=N/A,  N=40, Recruiting, 
    Trial completion date: Sep 2018 --> Dec 2018 | Trial primary completion date: Sep 2018 --> Dec 2018 Trial completion date: Jun 2018 --> Mar 2019 | Trial primary completion date: Apr 2018 --> Dec 2018
  • ||||||||||  Biomarker, Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date, Surgery:  Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery (clinicaltrials.gov) -  Jul 13, 2018   
    P=N/A,  N=26, Active, not recruiting, 
    Trial completion date: Jun 2018 --> Mar 2019 | Trial primary completion date: Apr 2018 --> Dec 2018 Recruiting --> Active, not recruiting | N=20 --> 26 | Trial completion date: Dec 2021 --> Sep 2018 | Trial primary completion date: Dec 2020 --> Sep 2018
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  Newborn Screening for Adrenoleukodystrophy (clinicaltrials.gov) -  Jul 12, 2018   
    P=N/A,  N=45796, Completed, 
    Recruiting --> Active, not recruiting | N=20 --> 26 | Trial completion date: Dec 2021 --> Sep 2018 | Trial primary completion date: Dec 2020 --> Sep 2018 Recruiting --> Completed | Trial completion date: Jun 2018 --> Aug 2017 | Trial primary completion date: Nov 2017 --> Aug 2017
  • ||||||||||  Enrollment change, Trial withdrawal:  Early Diagnosis Of Childhood Cerebral ALD (clinicaltrials.gov) -  Jul 6, 2018   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Completed | Trial completion date: Jun 2018 --> Aug 2017 | Trial primary completion date: Nov 2017 --> Aug 2017 N=100 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism (clinicaltrials.gov) -  Feb 28, 2018   
    P2,  N=4, Completed, 
    Trial primary completion date: Feb 2018 --> Aug 2017 Active, not recruiting --> Completed | Trial primary completion date: Jul 2019 --> Feb 2018 | Trial completion date: Jul 2020 --> Feb 2018
  • ||||||||||  Trial completion, Enrollment change:  Decision Support for Parents Receiving Information About Child's Rare Disease (clinicaltrials.gov) -  Feb 20, 2018   
    P=N/A,  N=63, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Jul 2019 --> Feb 2018 | Trial completion date: Jul 2020 --> Feb 2018 Active, not recruiting --> Completed | N=45 --> 63
  • ||||||||||  Metopirone (metyrapone) / HRA Pharma
    Trial completion, Trial primary completion date:  Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome (clinicaltrials.gov) -  Jan 29, 2018   
    P=N/A,  N=23, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2016
  • ||||||||||  Signifor (pasireotide) / Recordati
    Enrollment change, Trial withdrawal:  SOM230 Ectopic ACTH-producing Tumors (clinicaltrials.gov) -  Jan 26, 2018   
    P2,  N=0, Withdrawn, 
    Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2016 N=16 --> 0 | Recruiting --> Withdrawn
  • ||||||||||  Biomarker, Trial termination:  Evaluation of Molecular Markers in Adrenal Tumors (clinicaltrials.gov) -  Jan 17, 2018   
    P=N/A,  N=74, Terminated, 
    Recruiting --> Completed | Trial primary completion date: Feb 2016 --> Dec 2017 Completed --> Terminated; Slow/insufficient accrual
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  T2T@PSU: Tweens to Teens Project at Penn State (clinicaltrials.gov) -  Jan 8, 2018   
    P=N/A,  N=188, Completed, 
    Completed --> Terminated; Slow/insufficient accrual Recruiting --> Completed | N=300 --> 188 | Trial primary completion date: Jul 2011 --> Jul 2013
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome (clinicaltrials.gov) -  Dec 22, 2017   
    P=N/A,  N=1, Terminated, 
    Recruiting --> Completed | N=300 --> 188 | Trial primary completion date: Jul 2011 --> Jul 2013 N=10 --> 1 | Recruiting --> Terminated | Trial primary completion date: Jul 2015 --> Nov 2016; Recruitment problems
  • ||||||||||  Biomarker, Trial completion, Enrollment change:  Evaluation of Molecular Markers in Adrenal Tumors (clinicaltrials.gov) -  Dec 7, 2017   
    P=N/A,  N=71, Completed, 
    N=10 --> 1 | Recruiting --> Terminated | Trial primary completion date: Jul 2015 --> Nov 2016; Recruitment problems Recruiting --> Completed | N=500 --> 71
  • ||||||||||  Trial initiation date, Trial primary completion date, IO biomarker:  Early Diagnosis Of Childhood Cerebral ALD (clinicaltrials.gov) -  Dec 5, 2017   
    P=N/A,  N=100, Not yet recruiting, 
    Recruiting --> Completed | N=500 --> 71 Initiation date: Nov 2017 --> Nov 2018 | Trial primary completion date: Jul 2022 --> Jul 2023
  • ||||||||||  Clinical data, Trial primary completion date, Surgery:  Impact of Pre-operative Steroids on Adrenal Insufficiency (clinicaltrials.gov) -  Nov 17, 2017   
    P=N/A,  N=40, Recruiting, 
    Initiation date: Nov 2017 --> Nov 2018 | Trial primary completion date: Jul 2022 --> Jul 2023 Trial primary completion date: Dec 2017 --> Apr 2018
  • ||||||||||  nevanimibe (ATR-101) / Millendo Therap
    Trial completion, Trial primary completion date, Metastases:  Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma (clinicaltrials.gov) -  Nov 6, 2017   
    P1,  N=63, Completed, 
    Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Feb 2019 --> Nov 2016
  • ||||||||||  Trial initiation date, IO biomarker:  Early Diagnosis Of Childhood Cerebral ALD (clinicaltrials.gov) -  Oct 25, 2017   
    P=N/A,  N=100, Not yet recruiting, 
    Recruiting --> Completed | Trial primary completion date: Feb 2019 --> Nov 2016 Initiation date: Aug 2017 --> Nov 2017
  • ||||||||||  Qizenday (biotin) / MedDay
    Trial completion:  MD1003-AMN MD1003 in Adrenomyeloneuropathy (clinicaltrials.gov) -  Oct 9, 2017   
    P2/3,  N=67, Completed, 
    Enrolling by invitation --> Completed Active, not recruiting --> Completed
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date, Metastases:  Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer (clinicaltrials.gov) -  Sep 29, 2017   
    P2,  N=6, Terminated, 
    Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Feb 2016 N=40 --> 6 | Recruiting --> Terminated | Trial primary completion date: Dec 2011 --> Jul 2011; Slow enrollment
  • ||||||||||  Enrollment closed, Trial primary completion date:  Cortisol Response to Low Dose Cosyntropin Stimulation Test in the Late Afternoon (clinicaltrials.gov) -  Aug 22, 2017   
    P=N/A,  N=20, Active, not recruiting, 
    Trial primary completion date: Jul 2017 --> Dec 2020 Not yet recruiting --> Active, not recruiting | Trial primary completion date: Apr 2018 --> Aug 2017
  • ||||||||||  Minnebro (esaxerenone) / Daiichi Sankyo
    Trial completion:  Study of CS-3150 in Patients With Primary Aldosteronism (clinicaltrials.gov) -  Aug 14, 2017   
    P=N/A,  N=44, Completed, 
    Not yet recruiting --> Active, not recruiting | Trial primary completion date: Apr 2018 --> Aug 2017 Active, not recruiting --> Completed
  • ||||||||||  Trial completion:  Heart Disease Risk Factors in Major Depression (clinicaltrials.gov) -  Jun 30, 2017   
    P=N/A,  N=160, Completed, 
    Initiation date: Aug 2016 --> Dec 2017 | Trial primary completion date: Sep 2018 --> Feb 2019 Recruiting --> Completed
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date:  Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism (clinicaltrials.gov) -  Jun 9, 2017   
    P2,  N=4, Active, not recruiting, 
    Recruiting --> Completed | N=50 --> 89 | Trial primary completion date: Sep 2015 --> Jun 2016 Recruiting --> Active, not recruiting | N=66 --> 4 | Trial primary completion date: Jul 2018 --> Jul 2019
  • ||||||||||  prednisone / Generic mfg.
    Trial completion, Trial initiation date, Trial primary completion date:  Vapreda: Vaginal Prednisone Administration for Prevention of Adrenal Crisis (clinicaltrials.gov) -  May 30, 2017   
    P2,  N=12, Completed, 
    Recruiting --> Active, not recruiting | N=66 --> 4 | Trial primary completion date: Jul 2018 --> Jul 2019 Not yet recruiting --> Completed | Initiation date: Apr 2016 --> Jan 2017 | Trial primary completion date: Oct 2016 --> Apr 2017